Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,566 | -9,914 | -6,732 | -7,013 | -11,711 |
| Depreciation Amortization | 63 | 30 | 66 | 75 | 71 |
| Other Working Capital | 1,926 | -228 | -188 | 675 | 417 |
| Other Operating Activity | 565 | 1,032 | 490 | -812 | 6,033 |
| Operating Cash Flow | $-13,013 | $-9,080 | $-6,364 | $-7,075 | $-5,190 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -125 | N/A | -25 | -101 |
| Net Acquisitions | N/A | N/A | N/A | 1,450 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 250 | 0 |
| Investing Cash Flow | $-25 | $-125 | $N/A | $1,675 | $-101 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,400 | N/A | N/A |
| Common Stock Issued | 11,351 | 23,448 | N/A | 2,640 | N/A |
| Other Financing Activity | -253 | -201 | 6,049 | 1,811 | -160 |
| Financing Cash Flow | $11,098 | $23,247 | $8,449 | $4,452 | $-160 |
| Beginning Cash Position | 20,208 | 6,166 | 4,081 | 5,083 | 10,449 |
| End Cash Position | 18,268 | 20,208 | 6,166 | 4,081 | 5,083 |
| Net Cash Flow | $-1,940 | $14,042 | $2,086 | $-1,003 | $-5,366 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,013 | -9,080 | -6,364 | -7,075 | -5,190 |
| Capital Expenditure | -25 | -125 | N/A | -27 | -103 |
| Free Cash Flow | -13,038 | -9,205 | -6,364 | -7,102 | -5,292 |